ask="52.20"
ask_size="100"
average_daily_volume="1069360"
bid="50.55"
bid_size="600"
book_value="10.71"
change="-0.34"
change_from_200_day_moving_average="1.38"
change_from_50_day_moving_average="8.60"
change_from_52_week_high="-28.81"
change_From_52_week_low="19.92"
change_in_percent="-0.66%"
close="51.30"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.79"
ebitda="-409.46M"
eps_estimate_current_year="-5.09"
eps_estimate_next_quarter="-1.30"
eps_estimate_next_year="-4.74"
ex_dividend_date="N/A"
float_shares="71075000"
high="53.93"
high_52_weeks="80.11"
last_trade_date="3/1/2017"
last_trade_price="51.30"
last_trade_size="75818"
last_trade_time="4:00pm"
low="51.15"
low_52_weeks="31.38"
market_capitalization="4.41B"
moving_average_200_day="49.92"
moving_average_50_day="42.70"
name="Alnylam Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="62.73"
open="52.79"
pe_ratio="N/A"
peg_ratio="-0.20"
percent_change_from_200_day_moving_average="+2.77%"
percent_change_from_50_day_moving_average="+20.13%"
percent_change_from_52_week_high="-35.96%"
percent_change_from_52_week_low="+63.48%"
previous_close="51.64"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.82"
price_per_sales="94.19"
revenue="47.16M"
shares_outstanding="86013000"
short_ratio="10.08"
stock_exchange="NMS"
symbol="ALNY"
volume="994645"
weeks_range_52="31.38 - 80.11"
